Lismont M, Dreesen L, Wuttke S
[1] [4] Healthcare providers should document all significant injection site reactions in the medical record and report serious adverse events to the FDA MedWatch program
GLP-1 brands have been steadily expanding their reach through new indications, with Ozempic and Wegovy adding cardiovascular risk reduction in 2020 and 2024 respectively, and Zepbound adding obstructive sleep apnea in 2024
Start your intake How Weight Loss Medications Impact Menstrual Cycles GLP-1 receptor agonists work by slowing digestion, reducing hunger signals, and improving blood sugar control
Furthermore, GHK-Cu's role as a cofactor for the antioxidant enzyme superoxide dismutase (SOD) is complemented by its apparent ability to increase the expression of other antioxidant genes, providing a multi-pronged mechanism for investigating oxidative stress mitigation in cell-based assays
While these adverse events are significant, FAERS data alone doesnt establish a direct causal link between the medications and the reported fatalities